| Not Yet Recruiting | Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation NCT07358195 | Massachusetts General Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantati NCT07456189 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Not Yet Recruiting | Precision Physical Exercise for Personalized Onco-Hematology. NCT07286539 | University of Salamanca | N/A |
| Recruiting | The Florida ASCENT Study NCT07042243 | University of Florida | N/A |
| Recruiting | Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy NCT07173166 | Instituto de Investigacion Sanitaria INCLIVA | N/A |
| Recruiting | Early Detection of Complications During Immunotherapy for Haematological Malignancy NCT06377059 | Rigshospitalet, Denmark | N/A |
| Recruiting | Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantatio NCT06260111 | Universidad del Desarrollo | N/A |
| Completed | Coverage and Cost of Care Links- Telehealth NCT07409662 | Jean Edward | N/A |
| Unknown | Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD NCT06279585 | University of Seville | N/A |
| Recruiting | Intervention for Fatigue in HCT Recipients NCT05715047 | Massachusetts General Hospital | N/A |
| Recruiting | Hypnosis: a Path to Appeasement NCT05942885 | Hospices Civils de Lyon | N/A |
| Recruiting | Discontinuation Study NCT05866757 | University College Cork | N/A |
| Active Not Recruiting | Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in NCT05753501 | AbbVie | Phase 1 |
| Recruiting | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) NCT05375643 | Nadine McCleary, MD, MPH | N/A |
| Not Yet Recruiting | Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Res NCT05602168 | Institut Paoli-Calmettes | N/A |
| Completed | Improving Patient Experience: BMBA NCT05690230 | Thomas Jefferson University | N/A |
| Withdrawn | CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients NCT05061654 | Hamad Medical Corporation | Phase 4 |
| Recruiting | An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid a NCT05481502 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Recruiting | Improving Comprehensive Care of Cancer Patients NCT05323409 | Baylor College of Medicine | N/A |
| Active Not Recruiting | Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT NCT05493800 | MitoImmune Therapeutics | Phase 2 |
| Recruiting | Avera Cancer Sequencing and Analytics Protocol (ASAP) NCT05142033 | Avera McKennan Hospital & University Health Center | — |
| Completed | Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT NCT04966156 | University Health Network, Toronto | N/A |
| Unknown | Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS NCT05175508 | The First Affiliated Hospital of Soochow University | Phase 2 / Phase 3 |
| Unknown | TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS NCT04822974 | Institut Paoli-Calmettes | N/A |
| Completed | Coverage and Cost-of-Care (CC) Links- Financial Navigation Program NCT05465577 | Jean Edward | N/A |
| Unknown | The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality NCT04412135 | University Hospital, Limoges | — |
| Unknown | QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Di NCT05626764 | Hospices Civils de Lyon | — |
| Completed | Symptom Management for YA Cancer Survivors NCT04035447 | Duke University | N/A |
| Completed | CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients NCT04235153 | Hospices Civils de Lyon | — |
| Completed | Research-Action in Hematology From Hospitalization to Home NCT06053918 | University Hospital, Caen | — |
| Terminated | An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Canc NCT03955276 | University of California, San Diego | — |
| Unknown | Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Follow NCT03091933 | Ciusss de L'Est de l'Île de Montréal | Phase 1 / Phase 2 |
| Withdrawn | Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples NCT01792882 | Global BioClinical | — |
| Completed | A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Mu NCT00742560 | AbbVie (prior sponsor, Abbott) | Phase 2 |